اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA)  استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA  می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است
ADVIL از شرکت GLAXOSMITHKLINE
   New Drug Application (NDA): 201803
    
Company: GLAXOSMITHKLINE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS | 
|---|---|---|---|---|---|---|---|
| ADVIL | IBUPROFEN SODIUM | EQ 200MG BASE | TABLET;ORAL | Over-the-counter | 
 None  | 
Yes | Yes | 
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url | 
|---|---|---|---|---|---|---|---|
| 06/12/2012 | ORIG-1 | Approval | 
 Type 2 – New Active Ingredient  | 
 STANDARD  | 
 
  | 
         https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201803Orig1s000lbl.pdf  | 
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url | 
|---|---|---|---|---|---|
| 05/31/2018 | SUPPL-12 | Labeling-Container/Carton Labels | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201803Orig1s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/201803Orig1s012ltr.pdf  | 
||
| 04/12/2018 | SUPPL-11 | Labeling-Container/Carton Labels | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201803Orig1s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/201803Orig1s011ltr.pdf  | 
||
| 08/22/2017 | SUPPL-9 | Labeling-Container/Carton Labels | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201803Orig1s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/201803Orig1s009ltr.pdf  | 
||
| 06/12/2017 | SUPPL-8 | Labeling-Container/Carton Labels | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201803Orig1s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/201803Orig1s008ltr.pdf  | 
||
| 06/03/2016 | SUPPL-7 | Labeling-Container/Carton Labels | 
 https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201803Orig1s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/201803Orig1s007ltr.pdf  | 
||
| 11/05/2015 | SUPPL-6 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 01/03/2014 | SUPPL-3 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
||
| 08/15/2013 | SUPPL-1 | Manufacturing (CMC) | 
 Label is not available on this site.  | 
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert  | 
Note | Url | 
|---|---|---|---|---|---|
| 05/31/2018 | SUPPL-12 | 
 Labeling-Container/Carton Labels  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201803Orig1s012lbl.pdf | |
| 04/12/2018 | SUPPL-11 | 
 Labeling-Container/Carton Labels  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201803Orig1s011lbl.pdf | |
| 08/22/2017 | SUPPL-9 | 
 Labeling-Container/Carton Labels  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201803Orig1s009lbl.pdf | |
| 06/12/2017 | SUPPL-8 | 
 Labeling-Container/Carton Labels  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201803Orig1s008lbl.pdf | |
| 06/03/2016 | SUPPL-7 | 
 Labeling-Container/Carton Labels  | 
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201803Orig1s007lbl.pdf | |
| 06/12/2012 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201803Orig1s000lbl.pdf | 
ADVIL
The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.
TABLET;ORAL; EQ 200MG BASE
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | Application No. | Company | 
|---|---|---|---|---|---|---|---|
| ADVIL | IBUPROFEN SODIUM | EQ 200MG BASE | TABLET;ORAL | Over-the-counter | Yes | 201803 | GLAXOSMITHKLINE | 
                
                  
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
                                                
نظرات کاربران